Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s Life Science Investor Konference held in Copenhagen on November 27th 2024. Økonomisk Ugebrev, serves as a platform for collaboration and investment opportunities. Hamlet BioPharma presented the advances made by the company to a diverse audience and the presentation was followed by lively discussions.
The video from the event is now available on Hamlet BioPharma’s web site:
https://hamletbiopharma.com/news/media-archive/
For more information about Økonomisk Ugebrev, please visit Ugebrev’s official website.
For further information, please contact:
Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com
Martin Erixon, CEO Hamlet BioPharma, +46-733 00 43 77
